Review
doi: 10.1016/j.drudis.2006.06.012.
Screening the receptorome: an efficient approach for drug discovery and target validation
Affiliations
- PMID: 16846798
- DOI: 10.1016/j.drudis.2006.06.012
Item in Clipboard
Review
Screening the receptorome: an efficient approach for drug discovery and target validation
Drug Discov Today.
2006 Aug.
Abstract
The receptorome, comprising at least 5% of the human genome, encodes receptors that mediate the physiological, pathological and therapeutic responses to a vast number of exogenous and endogenous ligands. Not surprisingly, the majority of approved medications target members of the receptorome. Several in silico and physical screening approaches have been devised to mine the receptorome efficiently for the discovery and validation of molecular targets for therapeutic drug discovery. Receptorome screening has also been used to discover, and thereby avoid, the molecular targets responsible for serious and unforeseen drug side effects.
Similar articles
-
Screening the receptorome.J Psychopharmacol. 2006 Jul;20(4 Suppl):41-6. doi: 10.1177/1359786806066045. J Psychopharmacol. 2006. PMID: 16785269 Review.
-
Receptor systems: will mining the receptorome yield novel targets for pharmacotherapy?Pharmacol Ther. 2005 Oct;108(1):59-64. doi: 10.1016/j.pharmthera.2005.06.013. Pharmacol Ther. 2005. PMID: 16083965 Review.
-
Finding new tricks for old drugs: an efficient route for public-sector drug discovery.Nat Rev Drug Discov. 2005 Dec;4(12):1005-14. doi: 10.1038/nrd1900. Nat Rev Drug Discov. 2005. PMID: 16341065 Review.
-
Screening the receptorome to discover the molecular targets for plant-derived psychoactive compounds: a novel approach for CNS drug discovery.Pharmacol Ther. 2004 May;102(2):99-110. doi: 10.1016/j.pharmthera.2004.03.004. Pharmacol Ther. 2004. PMID: 15163592 Review.
-
Affinity-based screening techniques for enhancing lead discovery.Curr Opin Drug Discov Devel. 2004 Jul;7(4):411-6. Curr Opin Drug Discov Devel. 2004. PMID: 15338950 Review.
Cited by
-
Combinatory annotation of cell membrane receptors and signalling pathways of Bombyx mori prothoracic glands.Sci Data. 2016 Aug 30;3:160073. doi: 10.1038/sdata.2016.73. Sci Data. 2016. PMID: 27576083 Free PMC article.
-
Drug repurposing: far beyond new targets for old drugs.AAPS J. 2012 Dec;14(4):759-63. doi: 10.1208/s12248-012-9390-1. Epub 2012 Jul 24. AAPS J. 2012. PMID: 22826034 Free PMC article.
-
Drug Repurposing Is a New Opportunity for Developing Drugs against Neuropsychiatric Disorders.Schizophr Res Treatment. 2016;2016:6378137. doi: 10.1155/2016/6378137. Epub 2016 Mar 17. Schizophr Res Treatment. 2016. PMID: 27073698 Free PMC article. Review.
-
Analgesic effect of a mixed T-type channel inhibitor/CB2 receptor agonist.Mol Pain. 2013 Jul 1;9:32. doi: 10.1186/1744-8069-9-32. Mol Pain. 2013. PMID: 23815854 Free PMC article.
-
Mitigating risk in academic preclinical drug discovery.Nat Rev Drug Discov. 2015 Apr;14(4):279-94. doi: 10.1038/nrd4578. Nat Rev Drug Discov. 2015. PMID: 25829283 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
